RenukaVIyerMD

Oncology • Buffalo, NY

Professor, Medicine, University at Buffalo SUNY School of Medicine & Biomedical Sciences

Join to view full profile

Dr. Iyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Iyer's full profile

Already have an account?

Office
Elm And Carlton St
Buffalo, NY 14263
Phone+1 716-845-2300

Education & Training

University at BuffaloFellowship, Hematology and Medical Oncology, 2001 - 2004
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1998 - 2001
Grant Medical CollegeClass of 1995

Certifications & Licensure

NY State Medical License 2001 - 2026
American Board of Internal Medicine Medical Oncology

Clinical Trials

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2013 Jul 11
Completed
Phase 1, Phase 2
Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors Start of enrollment: 2015 May 15
Completed
Phase 2
Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer Start of enrollment: 2017 Dec 07
Active, not recruiting
Phase 1, Phase 2
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Canc...
Rachna T Shroff, Gentry King, Sarah Colby, Aaron J Scott, Mitesh J Borad
Journal of Clinical Oncology. 2025-02-10
Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreat...
Sarbajit Mukherjee, Harsha Pattnaik, Sahithi Sonti, Mrinalini Ramesh, Prantesh Jain
Cancers. 2025-01-12
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States.
Richard S Finn, Renuka Iyer, Richard S Kalman, Neehar D Parikh, Roniel Cabrera
Journal of Hepatocellular Carcinoma. 2025-01-01